Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

volociximab

A chimeric monoclonal antibody with potential antineoplastic activity. Volociximab binds to and inhibits the activity of alpha(5)beta(1) integrin, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-alpha 5 beta 1 integrin monoclonal antibody
anti-α5β1 integrin
Abbreviation:anti-α5β1 integrin MOAB
Code name:M200
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search